Company Data

Trevena Inc.

Advanced Market Data

Ticker

TRVN

Current Price

$0.25 20733.33%

Market Cap

$215.9K

Price Target

Refer to Report

Volume

2.3K

52wk Range

$0.001 - $7.85

Advanced Market Data

Overview

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Other Considerations

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Nutriband Inc.

NTRB (NSC)

$6.46

$6.53(-1.07%)

90.1M

3.7K

$2.97784 - $9.424

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Unicycive Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc.

UNCY (NSC)

$4.175

$4.2(-0.6%)

73.7M

111.1K

$2.833 - $11

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Cadrenal Therapeutics Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc.

CVKD (NSC)

$12.99

$13.29(-2.26%)

26.6M

11.9K

$6.89 - $22.9011

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

LakeShore Biopharma Co. Ltd.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

LakeShore Biopharma Co. Ltd.

LakeShore Biopharma Co. Ltd.

LSB (NSC)

$0.825472

$0.8(3.18%)

34.0M

8.1K

$0.59 - $8.6

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

MAIA Biotechnology Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

MAIA Biotechnology Inc.

MAIA Biotechnology Inc.

MAIA (AMX)

$1.48

$1.52(-2.63%)

48.8M

243.6K

$1.4 - $3.742

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

889.5K

$0.0137 - $3.4699

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Eledon Pharmaceuticals

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Eledon Pharmaceuticals

Eledon Pharmaceuticals

ELDN (Nasdaq)

$2.575

$2.57(0.19%)

154.2M

169.2K

$2.375 - $5.54

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Tonix Pharmaceuticals Holding Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp.

TNXP (Nasdaq)

$30.1

$30.81(-2.3%)

263.9M

397.6K

$6.76 - $130

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Ocugen, Inc.

OCGN (Nasdaq)

$1.025

$1.05(-2.38%)

299.6M

1.1M

$0.515 - $1.33

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PDS Biotechnology Corporation

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PDS Biotechnology Corporation

PDS Biotechnology Corporation

PDSB (Nasdaq)

$1.2

$1.24(-3.23%)

56.0M

265.0K

$0.8505 - $4.29

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data